178 related articles for article (PubMed ID: 33107985)
21. Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Ji Y; Chen S; Xiang B; Li K; Xu Z; Yao W; Lu G; Liu X; Xia C; Wang Q; Li Y; Wang C; Yang K; Yang G; Tang X; Xu T; Wu H
Int J Cancer; 2017 Aug; 141(4):848-855. PubMed ID: 28486787
[TBL] [Abstract][Full Text] [Related]
22. Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
Seligson ND; Awasthi A; Millis SZ; Turpin BK; Meyer CF; Grand'Maison A; Liebner DA; Hays JL; Chen JL
JAMA Netw Open; 2019 Oct; 2(10):e1912416. PubMed ID: 31577358
[TBL] [Abstract][Full Text] [Related]
23. Multicentric visceral epithelioid hemangioendothelioma, with extremity dermal deposits, unusual late recurrence on the nasal bridge, and TFE3 gene rearrangement.
Thway K; Mentzel T; Perrett CM; Calonje E
Hum Pathol; 2018 Feb; 72():153-159. PubMed ID: 28855107
[TBL] [Abstract][Full Text] [Related]
24. Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints.
Errani C; Sung YS; Zhang L; Healey JH; Antonescu CR
Cancer Genet; 2012; 205(1-2):12-7. PubMed ID: 22429593
[TBL] [Abstract][Full Text] [Related]
25. VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature.
Telli TA; Okten IN; Tuylu TB; Demircan NC; Arikan R; Alan O; Ercelep O; Ones T; Yildirim AT; Dane F; Yumuk PF
Curr Probl Cancer; 2020 Oct; 44(5):100568. PubMed ID: 32201052
[TBL] [Abstract][Full Text] [Related]
26. A Case of Large Meningeal Epithelioid Hemangioendothelioma With WWTR1-CAMTA1 Gene Rearrangement and Slow Growth Over 15 Years.
Süß P; Volz F; Lang C; Staszewksi O; Palmedo G; Taschner CA; Scheiwe C; Kurz P; Mentzel T; Prinz M
J Neuropathol Exp Neurol; 2018 Oct; 77(10):871-876. PubMed ID: 30085199
[TBL] [Abstract][Full Text] [Related]
27. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer.
Lau K; Massad M; Pollak C; Rubin C; Yeh J; Wang J; Edelman G; Yeh J; Prasad S; Weinberg G
Chest; 2011 Nov; 140(5):1312-1318. PubMed ID: 21546438
[TBL] [Abstract][Full Text] [Related]
28. Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcoma.
Schuetze SM; Zhao L; Chugh R; Thomas DG; Lucas DR; Metko G; Zalupski MM; Baker LH
Eur J Cancer; 2012 Jun; 48(9):1347-53. PubMed ID: 22525224
[TBL] [Abstract][Full Text] [Related]
29. Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements.
Shah AA; Ohori NP; Yip L; Coyne C; Antonescu CR; Seethala RR
Endocr Pathol; 2016 Jun; 27(2):147-52. PubMed ID: 27026033
[TBL] [Abstract][Full Text] [Related]
30. Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network.
Baldi GG; Lo Vullo S; Grignani G; Vincenzi B; Badalamenti G; Mastore M; Buonomenna C; Morosi C; Barisella M; Frezza AM; Provenzano S; Simeone N; Picozzi F; Mariani L; Casali PG; Stacchiotti S
Cancer; 2022 Apr; 128(7):1439-1448. PubMed ID: 35026050
[TBL] [Abstract][Full Text] [Related]
31. [Epithelioid hemangioendothelioma].
Cousin S; Le Loarer F; Crombé A; Karanian M; Minard-Colin V; Penel N
Bull Cancer; 2019 Jan; 106(1):73-83. PubMed ID: 30527817
[TBL] [Abstract][Full Text] [Related]
32. [Atypical epithelioid hemangioendothelioma: a clinicopathological analysis of eight cases].
Gong QX; Fan QH; Ding Y; Xiao QX; Wang QY; Tang JL; Song QY; Wang B
Zhonghua Bing Li Xue Za Zhi; 2019 Aug; 48(8):620-625. PubMed ID: 31422593
[No Abstract] [Full Text] [Related]
33. Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis.
Katz D; Azraq Y; Eleyan F; Gill S; Peretz T; Merimsky O
BMC Cancer; 2016 Aug; 16():616. PubMed ID: 27501793
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset.
Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A
Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740
[TBL] [Abstract][Full Text] [Related]
35. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study.
Stacchiotti S; Simeone N; Lo Vullo S; Morosi C; Greco FG; Gronchi A; Barisella M; Collini P; Zaffaroni N; Dagrada GP; Frezza AM; Mariani L; Casali PG
Eur J Cancer; 2019 Jan; 106():225-233. PubMed ID: 30528807
[TBL] [Abstract][Full Text] [Related]
36. Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement.
Suurmeijer AJH; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
Genes Chromosomes Cancer; 2020 Jul; 59(7):389-395. PubMed ID: 32170768
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of epithelioid hemangioendothelioma: a single-center retrospective study.
Wu X; Li B; Zheng C; Hong T; He X
Eur J Med Res; 2019 Feb; 24(1):16. PubMed ID: 30819247
[TBL] [Abstract][Full Text] [Related]
38. WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma.
Driskill JH; Zheng Y; Wu BK; Wang L; Cai J; Rakheja D; Dellinger M; Pan D
Genes Dev; 2021 Apr; 35(7-8):495-511. PubMed ID: 33766984
[TBL] [Abstract][Full Text] [Related]
39. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
Farhat F; Kattan JG; Ghosn M
Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
[TBL] [Abstract][Full Text] [Related]
40. Primary pleural epithelioid hemangioendothelioma: case report and review of the literature.
Lavacchi D; Voltolini L; Comin CE; Mazzoni F; Baldi GG; Briganti V; Luvarà S; Bongiolatti S; Antonuzzo L
Anticancer Drugs; 2021 Nov; 32(10):1131-1137. PubMed ID: 34232937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
